Erik Springer

Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.

Csaba Mahotka, Michael Wenzel, Erik Springer et al. · PubMed · 1999 · 358 citations

Medicine, Cancer Biology, Oncology +17

Actinomycosis of the jaws—histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis

Torsten Hansen, Martin Kunkel, Erik Springer et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2007 · 201 citations

Dentistry, Oral Medicine, Oral Pathology +16

Rac Affects Invasion of Human Renal Cell Carcinomas by Up-regulating Tissue Inhibitor of Metalloproteinases (TIMP)-1 and TIMP-2 Expression

Rainer Engers, Erik Springer, Frits Michiels et al. · Journal of Biological Chemistry · 2001 · 108 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

PD-L1 Expression and Immune Cell Infiltration in Gastroenteropancreatic (GEP) and Non-GEP Neuroendocrine Neoplasms With High Proliferative Activity

Martina Ferrata, Arno Schad, S. Zimmer et al. · Frontiers in Oncology · 2019 · 72 citations · Full text

Medicine, Immunology, Oncology +17

Detection of Papillary Thyroid Carcinoma by Analysis of BRAF and RET/PTC1 Mutations in Fine‐needle Aspiration Biopsies of Thyroid Nodules

Thomas J. Musholt, Christian Fottner, Matthias M. Weber et al. · World Journal of Surgery · 2010 · 71 citations

Medicine, Oncology, Pathology +16